Jennifer L Whitwell Selected Research

Proteins (Proteins, Gene)

1/2021	Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.
1/2021	Update on neuroimaging in Alzheimer's disease.
12/2020	Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
11/2019	Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
1/2019	Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease.
1/2019	Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.
1/2019	The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.
1/2018	Alzheimer's disease neuroimaging.
1/2018	Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
11/2017	Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer L Whitwell Research Topics

Disease

37	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 04/2007
35	Atrophy 06/2022 - 01/2006
16	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022 - 01/2004
15	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 06/2006
13	Dementia (Dementias) 01/2022 - 04/2007
12	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 11/2006
9	Tauopathies 01/2022 - 09/2015
9	Primary Progressive Aphasia 12/2019 - 05/2010
8	Cognitive Dysfunction 01/2021 - 12/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2007
7	Disease Progression 01/2021 - 06/2006
7	Corticobasal Degeneration 11/2020 - 06/2006
6	Apraxias (Dyspraxia) 09/2020 - 05/2010
6	Aphasia (Dysphasia) 01/2020 - 12/2013
5	Parkinsonian Disorders (Parkinsonism) 01/2022 - 02/2016
3	Pick Disease of the Brain (Pick's Disease) 11/2020 - 09/2005
3	Hippocampal Sclerosis 01/2020 - 01/2017
2	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 05/2020
2	Memory Disorders (Memory Loss) 01/2019 - 01/2014
2	Amyloid Plaque 01/2019 - 07/2008
2	Language Disorders (Language Disorder) 11/2014 - 03/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2014 - 03/2012
1	Vascular Diseases (Vascular Disease) 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Anomia (Dysnomia) 01/2021
1	Proteostasis Deficiencies 01/2020
1	Meningioma (Meningiomas) 12/2017
1	Seizures (Absence Seizure) 05/2016
1	Psychotic Disorders (Schizoaffective Disorder) 05/2016
1	Neoplasms (Cancer) 05/2016
1	Pseudobulbar Palsy 02/2016
1	Paralysis (Palsy) 02/2016
1	Parkinson Disease (Parkinson's Disease) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2012
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2008
1	Multiple Sclerosis 08/2008
1	Epilepsy (Aura) 08/2008
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2006

Drug/Important Bio-Agent (IBA)

23	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2013
19	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2008
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
17	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022 - 01/2012
13	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 12/2017
13	Amyloid beta-PeptidesIBA 01/2021 - 02/2008
9	Apolipoproteins E (ApoE)IBA 06/2022 - 11/2014
7	ApolipoproteinsIBA 06/2022 - 01/2014
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 05/2010
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020 - 12/2013
6	UbiquitinIBA 02/2008 - 09/2005
5	Biological ProductsIBA 01/2021 - 01/2004
4	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 01/2009
4	ProgranulinsIBA 01/2015 - 03/2007
3	LigandsIBA 01/2019 - 07/2017
2	Protein Isoforms (Isoforms)IBA 01/2022 - 10/2021
2	SynucleinsIBA 01/2022 - 01/2021
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 02/2016
2	alpha-SynucleinIBA 01/2017 - 09/2005
1	IronIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Neuroprotective AgentsIBA 10/2021
1	ioflupaneIBA 09/2020
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 09/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)IBA 05/2020
1	Prostaglandins FIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 07/2017
1	Apolipoprotein E4IBA 01/2017
1	SteroidsIBA 05/2016
1	PrionsIBA 04/2016
1	AD 20 (AD-20)IBA 03/2011
1	N 30IBA 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 01/2009
1	Protons (Proton)IBA 12/2008
1	HydrogenIBA 07/2008
1	Inositol (Myoinositol)IBA 07/2008
1	CreatineIBA 07/2008
1	N-acetylaspartate (N-acetyl aspartate)IBA 07/2008
1	Pharmaceutical PreparationsIBA 06/2006
1	tau Proteins (tau Protein)IBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 04/2008
1	Activities of Daily Living (ADL) 01/2016
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 12/2011